Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-23

Clinical Trial Update: Adapalene Gel 0.3% in the Treatment of Atrophic Acne Scars [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for adapalene gel 0.3% in the treatment of acne scars (completed; results posted).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Adapalene Gel 0.3% (adapalene)

Snippet

Sponsor: Galderma R&D | Conditions: Acne Scars | Phase 2 | Status: COMPLETED | Results posted: 2015-03-23